We included adults with type 2 diabetes who initiated a GLP-1 RA (exenatide [introduced in Israel in 12.2007], liraglutide [2.2010], lixisenatide [1.2015], exenatide extended-release [11.2015], dulaglutide [4.2016], and semaglutide [8.2019]) or basal insulin between February 2010 to December 2019
Vetter ML, Wadden TA, Teff KL, Khan ZF, Carvajal R, Ritter S, et al
Interestingly, compared to those in younger people, glutathione levels in older people are much lower, and the levels of oxidative stress are much higher
doi: 10.3389/fnagi.2016.00108 244 GejlMBrockBEgefjordLVangKRungbyJGjeddeA
GLP-1 receptor agonists like semaglutide take the spotlight, enhancing insulin secretion in response to elevated blood sugar levels